إعلان
إعلان
SNSE
Sensei Biotherapeutics, Inc. Common Stock
11.66
USDبرعاية
+0.60
+5.42%
٠٩ يناير, ١٥:٥٧ UTC -5
مغلق
بعد الإغلاق
11.09
-0.57
-4.89%
تقارير أرباح SNSE
النسبة الإيجابية المفاجئة
SNSE تفوق 12 من 20 آخر التقديرات.
60%
التقرير التالي
بيانات التقرير القادم
٢٦ مارس ٢٠٢٦
Estimate for Q4 25 (Revenue/ EPS)
--
/-$4.90
التغير الضمني من Q3 25 (Revenue/ EPS)
--
/+35.36%
التغير الضمني من Q4 24 (Revenue/ EPS)
--
/-20.97%
Sensei Biotherapeutics, Inc. Common Stock earnings per share and revenue
On ١٤ نوفمبر ٢٠٢٥, SNSE reported earnings of -3.62 USD per share (EPS) for Q3 25, beating the estimate of -4.19 USD, resulting in a 13.65% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a -11.25% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 3 المحللين forecast an EPS of -4.90 USD, with revenue projected to reach -- USD, implying an زيادة of 35.36% EPS, and زيادة of 0.00% in Revenue from the last quarter.
الأسئلة الشائعة
What were Sensei Biotherapeutics, Inc. Common Stock's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Sensei Biotherapeutics, Inc. Common Stock reported EPS of -$3.62, beating estimates by 13.65%, and revenue of $0.00, 0% as expectations.
How did the market react to Sensei Biotherapeutics, Inc. Common Stock's Q3 2025 earnings?
The stock price moved down -11.25%, changed from $9.02 before the earnings release to $8.01 the day after.
When is Sensei Biotherapeutics, Inc. Common Stock expected to report next?
The next earning report is scheduled for ٢٦ مارس ٢٠٢٦.
What are the forecasts for Sensei Biotherapeutics, Inc. Common Stock's next earnings report?
Based on 3
المحللين, Sensei Biotherapeutics, Inc. Common Stock is expected to report EPS of -$4.90 and revenue of -- for Q4 2025.
Which companies are reporting earnings today?
شيك FXEmpire's Earnings Calendar for today's list of reporting companies.
إعلان